MEDICINA
Departamento
Hospital General de Granollers
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital General de Granollers (20)
2024
-
The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Clinical and Translational Oncology
2023
-
A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study
Hematology (United Kingdom), Vol. 28, Núm. 1
-
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study
Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127
-
Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study
Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693
2022
-
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*
British Journal of Dermatology, Vol. 186, Núm. 1, pp. 142-152
-
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270
2021
2020
-
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases
British Journal of Dermatology, Vol. 183, Núm. 1, pp. 71-77
-
Maculopapular eruptions associated to COVID-19: A subanalysis of the COVID-Piel study
Dermatologic Therapy, Vol. 33, Núm. 6
-
Phase III study to evaluate patient’s preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
European Journal of Cancer Care, Vol. 29, Núm. 4
2019
-
Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study
Clinical Breast Cancer, Vol. 19, Núm. 2, pp. 105-112
2016
-
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302
2015
-
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43
-
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
British Journal of Haematology, Vol. 169, Núm. 1, pp. 111-116
2014
-
Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy
Tumori, Vol. 100, Núm. 2, pp. 225-231
2013
2009
-
Sustained ventricular arrhythmias in unstable angina patients: Results of the ARIAM database
Medical Science Monitor, Vol. 15, Núm. 6
2007
-
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia
European Journal of Haematology, Vol. 78, Núm. 2, pp. 102-110
2006
-
Bloqueo auriculoventricular en la angina inestable. Resultados del registro ARIAM
Medicina Intensiva, Vol. 30, Núm. 9, pp. 432-439
2002
-
Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases
Medicina Clinica, Vol. 118, Núm. 13, pp. 487-492